Do QALYs Matter in the U.S.?

Do QALYs Matter in the U.S.?

Do QALYs Matter in the U.S.?Nicole Coustier
Published on: 11/03/2025

QALYs are essential in Europe—but not in the U.S. Here's what really drives MedTech coverage decisions and how to pivot.

Payer Coverage
Payer Policy Is Poised to Unlock the Full Potential of AI in MedTech in 2025

Payer Policy Is Poised to Unlock the Full Potential of AI in MedTech in 2025

Payer Policy Is Poised to Unlock the Full Potential of AI in MedTech in 2025Nicole Coustier
Published on: 17/12/2024

U.S. payers are evolving fast. Here’s how AI-driven MedTech innovators can lead—not wait—for reimbursement models.

Payer Coverage
Medicare Proposes to Approve 80% of Transitional Pass Through Applications for Novel Tech in 2025

Medicare Proposes to Approve 80% of Transitional Pass Through Applications for Novel Tech in 2025

Medicare Proposes to Approve 80% of Transitional Pass Through Applications for Novel Tech in 2025Nicole Coustier
Published on: 25/08/2024

CMS is signaling support for innovation. Here's what this policy shift could mean for your device.

U.S. Healthcare Fundamentals
Wow. TCET Actually Happened.

Wow. TCET Actually Happened.

Wow. TCET Actually Happened.Nicole Coustier
Published on: 14/08/2024

A breakdown of the finalized TCET rule and what it means for Breakthrough Devices.

U.S. Healthcare Fundamentals